317 related articles for article (PubMed ID: 11163213)
21. Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor.
Ravichandran LV; Chen H; Li Y; Quon MJ
Mol Endocrinol; 2001 Oct; 15(10):1768-80. PubMed ID: 11579209
[TBL] [Abstract][Full Text] [Related]
22. Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B.
Milarski KL; Zhu G; Pearl CG; McNamara DJ; Dobrusin EM; MacLean D; Thieme-Sefler A; Zhang ZY; Sawyer T; Decker SJ
J Biol Chem; 1993 Nov; 268(31):23634-9. PubMed ID: 7693694
[TBL] [Abstract][Full Text] [Related]
23. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells.
Boute N; Boubekeur S; Lacasa D; Issad T
EMBO Rep; 2003 Mar; 4(3):313-9. PubMed ID: 12634852
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
[TBL] [Abstract][Full Text] [Related]
26. Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation.
Frank C; Keilhack H; Opitz F; Zschörnig O; Böhmer FD
Biochemistry; 1999 Sep; 38(37):11993-2002. PubMed ID: 10508402
[TBL] [Abstract][Full Text] [Related]
27. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT).
Roller PP; Wu L; Zhang ZY; Burke TR
Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503
[TBL] [Abstract][Full Text] [Related]
30. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
31. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of human protein tyrosine phosphatase 1B.
Barford D; Flint AJ; Tonks NK
Science; 1994 Mar; 263(5152):1397-404. PubMed ID: 8128219
[TBL] [Abstract][Full Text] [Related]
33. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
[TBL] [Abstract][Full Text] [Related]
34. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.
Puius YA; Zhao Y; Sullivan M; Lawrence DS; Almo SC; Zhang ZY
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13420-5. PubMed ID: 9391040
[TBL] [Abstract][Full Text] [Related]
35. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.
Kovalenko M; Denner K; Sandström J; Persson C; Gross S; Jandt E; Vilella R; Böhmer F; Ostman A
J Biol Chem; 2000 May; 275(21):16219-26. PubMed ID: 10821867
[TBL] [Abstract][Full Text] [Related]
36. Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases.
Ramachandran C; Aebersold R; Tonks NK; Pot DA
Biochemistry; 1992 May; 31(17):4232-8. PubMed ID: 1373652
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for substrate specificity of protein-tyrosine phosphatase 1B.
Sarmiento M; Zhao Y; Gordon SJ; Zhang ZY
J Biol Chem; 1998 Oct; 273(41):26368-74. PubMed ID: 9756867
[TBL] [Abstract][Full Text] [Related]
38. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells.
Romsicki Y; Reece M; Gauthier JY; Asante-Appiah E; Kennedy BP
J Biol Chem; 2004 Mar; 279(13):12868-75. PubMed ID: 14722096
[TBL] [Abstract][Full Text] [Related]
39. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.
Ahmad F; Li PM; Meyerovitch J; Goldstein BJ
J Biol Chem; 1995 Sep; 270(35):20503-8. PubMed ID: 7544790
[TBL] [Abstract][Full Text] [Related]
40. Intramolecular interactions in protein tyrosine phosphatase RPTPmu: kinetic evidence.
Aricescu AR; Fulga TA; Cismasiu V; Goody RS; Szedlacsek SE
Biochem Biophys Res Commun; 2001 Jan; 280(1):319-27. PubMed ID: 11162517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
